LifeStance Health Group, Inc. (LFST) Q3 2024 Earnings Call Transcript
LifeStance Health Group, Inc. (NASDAQ:LFST ) Q3 2024 Earnings Conference Call November 7, 2024 8:30 AM ET Company Participants Monica Prokocki - Vice President of Investor Relations Ken Burdick - Chief Executive Officer Dave Bourdon - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Jack Senft - William Blair Jamie Perse - Goldman Sachs Stephanie Davis - Barclays Operator Thank you for standing by. My name is Liz and I'll be your conference operator today.
LifeStance Health Group (LFST) Reports Q3 Loss, Tops Revenue Estimates
LifeStance Health Group (LFST) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.17 per share a year ago.
Wall Street Analysts Think LifeStance Health (LFST) Could Surge 26.68%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 26.7% in LifeStance Health (LFST). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
LifeStance Health Group: Long-Term Growth With Adj. EBITDA Margin Inflection Upwards
LFST has a strong value proposition for patients and is well-positioned to grow due to the increasing demand for mental health services in the US. Recent positive financial results show improved revenue and adj EBITDA margins, giving confidence in LFST's ability to achieve double-digit margins by FY25. The hybrid model of in-person and telehealth services provides advantages for both patients and LFST, leading to increased patient adoption and potential for continued growth.
Wall Street Analysts Believe LifeStance Health (LFST) Could Rally 39.38%: Here's is How to Trade
The mean of analysts' price targets for LifeStance Health (LFST) points to a 39.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
LifeStance Health Group, Inc. (LFST) Q2 2024 Earnings Call Transcript
LifeStance Health Group, Inc. (NASDAQ:LFST ) Q2 2024 Earnings Conference Call August 8, 2024 8:30 AM ET Company Participants Monica Prokocki - Vice President of Investor Relations Ken Burdick - Chief Executive Officer Dave Bourdon - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Lisa Gill - JPMorgan Jack Senft - William Blair Dylan Finley - UBS Jack Slevin - Jefferies Stephanie Davis - Barclays Operator Thank you for standing by. My name is Jermanie, and I will be your conference operator today.
LifeStance Health Group (LFST) Reports Q2 Loss, Tops Revenue Estimates
LifeStance Health Group (LFST) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.13 per share a year ago.
Lost Money on LifeStance Health Group, Inc.(LFST)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
NEW YORK, NY / ACCESSWIRE / August 6, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of LifeStance Health Group, Inc. ("LifeStance") (NASDAQ:LFST) concerning possible violations of federal securities laws. LifeStance is the subject of a report published by Hindenburg Research on February 1, 2024, titled: "LifeStance: A Private Equity-Backed Mental Health Rollup Headed For A Breakdown.
Shareholders that lost money on LifeStance Health Group, Inc.(LFST) should contact Levi & Korsinsky about Securities Fraud Investigation - LFST
NEW YORK, NY / ACCESSWIRE / August 5, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of LifeStance Health Group, Inc. ("LifeStance") (NASDAQ:LFST) concerning possible violations of federal securities laws. LifeStance is the subject of a report published by Hindenburg Research on February 1, 2024, titled: "LifeStance: A Private Equity-Backed Mental Health Rollup Headed For A Breakdown.
An Investigation Has Commenced on Behalf of LifeStance Health Group, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your LFST Losses
NEW YORK, NY / ACCESSWIRE / August 2, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of LifeStance Health Group, Inc. ("LifeStance") (NASDAQ:LFST) concerning possible violations of federal securities laws. LifeStance is the subject of a report published by Hindenburg Research on February 1, 2024, titled: "LifeStance: A Private Equity-Backed Mental Health Rollup Headed For A Breakdown.
LifeStance Health Group (LFST) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
LifeStance Health (LFST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Lost Money on LifeStance Health Group, Inc. (LFST)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / August 1, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of LifeStance Health Group, Inc. ("LifeStance") (NASDAQ:LFST) concerning possible violations of federal securities laws. LifeStance is the subject of a report published by Hindenburg Research on February 1, 2024, titled: "LifeStance: A Private Equity-Backed Mental Health Rollup Headed For A Breakdown.
